Accessibility Menu
Kaya logo

Kaya(OTC) KAYS

Current Price$0.00
Market Cap$205.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)-100%
5 Year-100%
1 Year-99%
1 Month-98%
Kaya last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-24
Kaya stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-94.83%USD 0.012026-07-17
1 month-97.56%USD 0.012026-06-24
3 month-99.27%USD 0.042026-04-24
Year to date-99.24%USD 0.042025-12-31
1 year-98.72%USD 0.022025-07-24
3 year-99.45%USD 0.062023-07-25
5 year-99.89%USD 0.272021-07-23
Since inception-100%USD 75.002010-01-07

Kaya Financials at a Glance

Market Cap

$205.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

-$1.32K

Net Income (TTM)

-$11.75M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.62 (Low)

Price

$0.00

Volume

23,172

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.06

Estimated Earnings Date

May 19, 2026

KAYS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kaya

Kaya Holdings runs a licensed psychedelic treatment center in Oregon. It offers supervised psilocybin therapy for adults seeking mental health support. The company also manages international cannabis projects, but these do not generate revenue yet.

Products and Services

  • Psychedelic Treatment Facility: The Sacred Mushroom center in Oregon offers supervised psilocybin therapy, which constitutes substantially all ongoing revenue.
  • Group Therapy Sessions: Organized group psilocybin sessions for adults seeking mental health support.
  • International Cannabis Projects: Early-stage medical cannabis initiatives in Greece and Israel (0% of current revenue).
  • Discontinued Cannabis Retail: Former retail stores and branded cannabis products in the U.S. (operations ended in 2024).
  • Ancillary Brands: Cannabis-related glassware and apparel, not currently contributing to revenue.

Growth and Expansion

  • Launched The Sacred Mushroom psilocybin center in Portland, Oregon in July 2024.
  • Transitioned staff to independent contractors in April 2025 to reduce costs.
  • Entered agreement to sell last Oregon cannabis license in June 2025 (pending approval).
  • Developed international cannabis projects through Kaya Brands International in Greece and Israel since 2019.

What Makes Kaya Holdings Special

Kaya Holdings is one of the first U.S. public companies to operate a licensed psilocybin treatment center. The company uses its cannabis industry experience to navigate new psychedelic regulations. Its international projects position it for future growth in medical cannabis markets.

Five Things You Need to Know

  • Net sales were $10,097 in Q2 2025, down 81.7% from Q2 2023.
  • Gross profit was $3,362 in Q2 2025, down 90.5% from Q2 2023.
  • Operating loss improved to $-162,584 in Q2 2025, a 59.3% YoY improvement.
  • Cash used in operations was $-207,259 in Q2 2025, a 28.8% improvement from Q2 2024.
  • Working capital deficiency reached $12 million as of June 30, 2025.

Bottom Line

Kaya Holdings has shifted from cannabis retail to psychedelic therapy services. The company faces financial challenges but is adapting its business model for new markets.

AI Generated • Apr 16, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

2

CEO

Craig R. Frank

Website

www.kayaholdings.com

Headquarters

Boca Raton, FL 33304, US

KAYS Financials

Key Financial Metrics (TTM)

Gross Margin

32.39%

Operating Margin

-3285.60%

Net Income Margin

-56783.05%

Return on Equity

105.78%

Return on Capital

N/A

Return on Assets

-6424.90%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$205.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

686.44M

Volume

23.17K

Avg. Volume

6.13K

Financials (TTM)

Gross Profit

$4.21K

Operating Income

-$985.13K

EBITDA

-$10.33M

Operating Cash Flow

-$729.71K

Capital Expenditure

-$8.37K

Free Cash Flow

-$738.08K

Cash & ST Invst.

$26.09K

Total Debt

$580.05K

Kaya Performance Analysis

Kaya annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 889,899N/A
20222022-12-31USD 685,379-23.0%
20232023-12-31USD 0N/A
20242024-12-31USD 7,134N/A
Kaya sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-895.8%
Q12025-03-31129.5%
Q22025-06-3043.2%
Q32025-09-30-46.4%
Kaya annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.13N/A
20222022-12-31USD -0.24N/A
20232023-12-31USD 0.01N/A
20242024-12-31USD -0.07N/A
Kaya sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31234.2%
Q12025-03-31-228.9%
Q22025-06-30-57.6%
Q32025-09-304.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$5.41K

+80.3%

Gross Profit

$1.86K

-31.7%

Gross Margin

34.43%

N/A

Market Cap

$205.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$102.95K

N/A

Employees

2

N/A

Net Income

-$8.59M

-249.7%

EBITDA

-$8.01M

-260.8%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

$26.09K

-59.7%

Total Debt

$580.05K

-93.6%

Accounts Receivable

$0.00

N/A

Inventory

$348.00

+45.0%

Long Term Debt

$385.74K

-95.6%

Short Term Debt

$194.31K

-37.4%

Return on Assets

-64.25%

N/A

Return on Invested Capital

31.74%

N/A

Free Cash Flow

-$68.83K

+72.9%

Operating Cash Flow

-$68.83K

+72.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KOANResonate Blends, Inc.
$0.00+0.00%
BHNGFBhang Inc.
$0.00+0.00%
BSPKBespoke Extracts, Inc.
$0.00+0.00%
KHRNFKhiron Life Sciences Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About KAYS

What is the current price of Kaya?

Kaya is trading at $0.00 per share.

What is the 52-week range for Kaya?

Over the past 52 weeks, Kaya has traded between $0.00 and $0.06.

How much debt does Kaya have?

As of the most recent reporting period, Kaya reported total debt of $580.05K.

How much cash does Kaya have on hand?

Kaya reported $26.09K in cash and cash equivalents in its most recent financial results.

What is Kaya’s dividend yield?

Kaya does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services